About 1 million American people have Parkinson's disease, a progressive disorder of the central nervous system. There are treatments that can temporarily improve the symptoms, but there is not a cure. Now, a five-year study is being kick off at 18 research sites around the world, including one in Chicago, to speed up the growth of treatments to slow or stop the progression of this disease. The Parkinson's Progression Markers scheme, a study funded with $40 million from the Michael J. Fox Foundation, will be enrolling 400 recently diagnosed patients with Parkinson's and 200 people who do not have the disease.
Northwestern Medicine's Parkinson's Disease and Movement Disorders Center in Chicago hope to enroll 20 people to contribute for two years, according to the foundation. Northwestern are one of 14 research sites in the U.S., and the only one in the Midwest contribute in the study. Researchers will be seemed for the biomarkers for Parkinson's disease. "Parkinson's is a disease without a clear-cut diagnosis and without a cure," Dr. Tanya Simuni, principal examiner for the study at Northwestern and director of the Parkinson's Disease and group Disorders Center, said in a news release. "While significant strides have been made in the growth of drugs to manage the disease, hope for the prospect lies in the development of new drugs to slow or stop the progression of Parkinson's."
The four main symptoms of Parkinson's are tremor or trembling in the hands, arms, legs, jaw and face, stiffness of the limbs and trunk, slowness of group and impaired balance and coordination, according to the National Institute of Neurological Disorders and Stroke. Over time, people with Parkinson's have trouble walking, talking and responsibility simple tasks. Parkinson's typically influence people over age 50. Michael J. Fox was diagnosed with young-onset Parkinson's 19 years ago.
useful links : transport rankings
Northwestern Medicine's Parkinson's Disease and Movement Disorders Center in Chicago hope to enroll 20 people to contribute for two years, according to the foundation. Northwestern are one of 14 research sites in the U.S., and the only one in the Midwest contribute in the study. Researchers will be seemed for the biomarkers for Parkinson's disease. "Parkinson's is a disease without a clear-cut diagnosis and without a cure," Dr. Tanya Simuni, principal examiner for the study at Northwestern and director of the Parkinson's Disease and group Disorders Center, said in a news release. "While significant strides have been made in the growth of drugs to manage the disease, hope for the prospect lies in the development of new drugs to slow or stop the progression of Parkinson's."
The four main symptoms of Parkinson's are tremor or trembling in the hands, arms, legs, jaw and face, stiffness of the limbs and trunk, slowness of group and impaired balance and coordination, according to the National Institute of Neurological Disorders and Stroke. Over time, people with Parkinson's have trouble walking, talking and responsibility simple tasks. Parkinson's typically influence people over age 50. Michael J. Fox was diagnosed with young-onset Parkinson's 19 years ago.
useful links : transport rankings
No comments:
Post a Comment